DDW 2022 Conference Coverage
Playback speed
10 seconds
An Update on the Long-Term Safety and Efficacy of Ustekinumab in Bionaive Patients With Crohn's Disease and Ulcerative Colitis
By
DDW 2022 Conference Coverage
FEATURING
Stephen Hanauer
By
DDW 2022 Conference Coverage
FEATURING
Stephen Hanauer
263 views
June 7, 2022
Comments 0
Login to view comments.
Click here to Login
Videos